Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites

NCT04058613 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

304

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis

Interventions

DRUG: ALB Protein, Human
OTHER: placebo

Sponsor

Institute of Liver and Biliary Sciences, India